Hypotonia-Cystinuria Syndrome
|
0.680 |
GeneticVariation
|
disease |
BEFREE |
Hypotonia-Cystinuria syndrome (HCS) is a rare disease, caused by a mutation in two contiguous genes (SLC3A1 and PREPL) localized on chromosome 2p21, and it is characterized by both renal involvement with cystine stones and nervous involvement with hypotonia.
|
31024870 |
2019 |
Hypotonia-Cystinuria Syndrome
|
0.680 |
GeneticVariation
|
disease |
BEFREE |
Hypotonia-cystinuria syndrome is a very rare autosomal recessive contiguous gene deletion syndrome of PREPL and SLC3A1 at 2p21 with neuromuscular and neuroendocrinologic presentation.
|
29627929 |
2018 |
Hypotonia-Cystinuria Syndrome
|
0.680 |
GeneticVariation
|
disease |
BEFREE |
Different recessive contiguous gene deletion syndromes involving PREPL and a variable combination of SLC3A1 (hypotonia-cystinuria syndrome), CAMKMT (atypical hypotonia-cystinuria syndrome), and PPM1B (2p21 deletion syndrome) have been described.
|
28726805 |
2018 |
Hypotonia-Cystinuria Syndrome
|
0.680 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Advantages and pitfalls of an extended gene panel for investigating complex neurometabolic phenotypes.
|
27604308 |
2016 |
Hypotonia-Cystinuria Syndrome
|
0.680 |
Biomarker
|
disease |
CTD_human |
Calmodulin Methyltransferase Is Required for Growth, Muscle Strength, Somatosensory Development and Brain Function.
|
26247364 |
2015 |
Hypotonia-Cystinuria Syndrome
|
0.680 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
PREPL deficiency with or without cystinuria causes a novel myasthenic syndrome.
|
24610330 |
2014 |
Hypotonia-Cystinuria Syndrome
|
0.680 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
PREPL deficiency with or without cystinuria causes a novel myasthenic syndrome.
|
24610330 |
2014 |
Hypotonia-Cystinuria Syndrome
|
0.680 |
GeneticVariation
|
disease |
BEFREE |
Hypotonia-cystinuria syndrome (HCS) is an autosomal recessive disorder caused by combined deletions of SLC3A1 and PREPL.
|
22796000 |
2012 |
Hypotonia-Cystinuria Syndrome
|
0.680 |
GeneticVariation
|
disease |
BEFREE |
In addition to isolated cystinuria, patients suffering from the hypotonia-cystinuria syndrome have been reported carrying deletions including at least the SLC3A1 and the PREPL genes in 2p21.
|
22480232 |
2012 |
Hypotonia-Cystinuria Syndrome
|
0.680 |
GeneticVariation
|
disease |
BEFREE |
Patients with HCS are missing both alleles of SLC3A1 and PREPL.
|
18781961 |
2008 |
Hypotonia-Cystinuria Syndrome
|
0.680 |
GeneticVariation
|
disease |
BEFREE |
Hypotonia-cystinuria syndrome (HCS) is a recessive disorder caused by microdeletions of SLC3A1 and PREPL on chromosome 2p21.
|
17579669 |
2007 |
Hypotonia-Cystinuria Syndrome
|
0.680 |
ChromosomalRearrangement
|
disease |
ORPHANET |
Taken together, these results suggest that PREPL is a novel oligopeptidase, with unique structural and functional characteristics, involved in hypotonia-cystinuria syndrome.
|
16385448 |
2006 |
Hypotonia-Cystinuria Syndrome
|
0.680 |
GeneticVariation
|
disease |
BEFREE |
The prolyl endopeptidase-like protein PREPL has recently attracted attention because its gene is located within two contiguous gene-deletion syndromes, the 2p21 deletion syndrome and the hypotonia-cystinuria syndrome.
|
16913837 |
2006 |
MYASTHENIC SYNDROME, CONGENITAL, 22
|
0.430 |
Biomarker
|
disease |
BEFREE |
PREPL protein and reactivity were absent in lymphocytes from subjects with PREPL deficiency, but normal in the clinically similar Prader-Willi syndrome.ConclusionPREPL deficiency causes neuromuscular, autonomic, cognitive, endocrine, and dysmorphic clinical features.
|
28726805 |
2018 |
MYASTHENIC SYNDROME, CONGENITAL, 22
|
0.430 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Congenital myasthenic syndromes: recent advances.
|
27472506 |
2016 |
MYASTHENIC SYNDROME, CONGENITAL, 22
|
0.430 |
GeneticVariation
|
disease |
CLINVAR |
PREPL deficiency with or without cystinuria causes a novel myasthenic syndrome.
|
24610330 |
2014 |
MYASTHENIC SYNDROME, CONGENITAL, 22
|
0.430 |
CausalMutation
|
disease |
CLINVAR |
PREPL deficiency with or without cystinuria causes a novel myasthenic syndrome.
|
24610330 |
2014 |
MYASTHENIC SYNDROME, CONGENITAL, 22
|
0.430 |
GeneticVariation
|
disease |
BEFREE |
The proband harbors a paternally inherited nonsense mutation in PREPL and a maternally inherited deletion involving both PREPL and SLC3A1; therefore, the PREPL deficiency determines the phenotype.
|
24610330 |
2014 |
MYASTHENIC SYNDROME, CONGENITAL, 22
|
0.430 |
GeneticVariation
|
disease |
BEFREE |
Deletion of the Prolyl Endopeptidase-like (PREPL) gene has been described in three contiguous gene deletion syndromes at the 2p21 locus and current developments in high resolution microarrays and whole genome sequencing will no doubt soon result in the identification of isolated PREPL deficiency.
|
21222627 |
2011 |
Lambert-Eaton Myasthenic Syndrome
|
0.300 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Congenital myasthenic syndromes: recent advances.
|
27472506 |
2016 |
Myasthenic Syndrome
|
0.300 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Congenital myasthenic syndromes: recent advances.
|
27472506 |
2016 |
biotin-[acetyl-CoA-carboxylase] ligase activity
|
0.300 |
Biomarker
|
phenotype |
GENOMICS_ENGLAND |
HCS is caused by recessive deletions involving the SLC3A1 and PREPL genes.
|
24610330 |
2014 |
Intellectual Disability
|
0.300 |
Biomarker
|
group |
GENOMICS_ENGLAND |
PREPL deficiency with or without cystinuria causes a novel myasthenic syndrome.
|
24610330 |
2014 |
2p21 microdeletion syndrome without cystinuria
|
0.300 |
ChromosomalRearrangement
|
disease |
ORPHANET |
Further delineation of genotype-phenotype correlation in homozygous 2p21 deletion syndromes: first description of patients without cystinuria.
|
23794250 |
2013 |
2p21 microdeletion syndrome
|
0.300 |
ChromosomalRearrangement
|
disease |
ORPHANET |
A recessive contiguous gene deletion of chromosome 2p16 associated with cystinuria and a mitochondrial disease.
|
11524703 |
2001 |